Company Number: 13455805

Analysis Date: 2025-07-20 17:59 UTC

Financial Health Assessment for YAHPHARM LTD (as of 30 June 2024)

---

1. Financial Health Score: B

Explanation:
YAHPHARM LTD demonstrates a generally sound financial position with an improving net asset base and healthy working capital. The company has successfully converted a very low equity base (£1) into a small but positive net asset value (£3,594), indicating growth and strengthening financial stability. However, as a micro-entity with relatively modest absolute figures, it faces natural limitations in scale and resilience, so a "B" grade reflects good health but some caution due to size and early stage.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Net Assets (Shareholders’ Funds)	£3,594	Positive net assets signal solvency and the ability to cover liabilities with assets.
Net Current Assets (Working Capital)	£3,445	Healthy working capital indicates the company can comfortably meet short-term obligations.
Current Assets	£7,941	Cash, receivables, and stock are sufficient to cover current liabilities (£4,496).
Current Liabilities	£4,496	Moderate level of short-term debts; manageable given current assets.
Fixed Assets	£149	Minimal investment in long-term assets, typical for a micro entity in service sector.
Equity Growth	From £1 (2023) to £3,594 (2024)	Significant improvement in retained earnings or capital injection.
Employee Count	1	Very small scale, indicating limited operational complexity or initial growth phase.

---

3. Diagnosis: What the Numbers Reveal

YAHPHARM LTD shows the classic "symptoms of early-stage recovery and growth." From a near-zero equity base, the company has bolstered its net assets and working capital substantially within a year. This suggests either a capital injection or profitable operations improving retained earnings, though the absence of P&L detail limits precise profit analysis.

• Healthy cash flow indicator: The increase in current assets coupled with reduced current liabilities points to improved liquidity. This "healthy cash flow" symptom means the company should be able to meet immediate obligations without stress.
• Low fixed asset base: Reflects a service-oriented business, typical for human health activities, with limited capital expenditure needs.
• Single director control: The company is tightly controlled by one person who is also the sole significant shareholder, which simplifies governance but can limit external oversight.
• Compliance and governance: On-time filing of accounts and confirmation statements indicates good compliance with statutory requirements, an important "vital sign" for regulatory health.

Potential concerns include the small absolute size of net assets and reliance on a single individual, which may constrain growth capacity and risk diversification.

---

4. Recommendations: Steps to Improve Financial Wellness

• Build Reserves: Continue to strengthen retained earnings to create a buffer against unexpected expenses or downturns.
• Diversify Revenue Streams: Explore expanding services or partnerships within the health sector to increase turnover and reduce reliance on a single income source.
• Consider External Financing: If growth is a goal, external investment or loans can provide capital for expansion, but must be balanced carefully to maintain solvency.
• Enhance Financial Reporting: Prepare and monitor profit and loss statements regularly to better understand earnings quality and margins.
• Governance Review: As the company grows, consider appointing additional directors or advisors to broaden expertise and oversight.
• Cash Flow Management: Maintain vigilant monitoring of cash flows to avoid liquidity crunches, especially given the micro-entity scale.
• Plan for Scale: Assess operational capacity, including staffing, to ensure the company can meet increased demand without stretching resources thin.

---